advanced search
ASSURE INHALER SAFETY & PERFORMANCE: POLYMERS, COLOUR & ADDITIVES
EXPERT VIEW
Stephen Duckworth
ASSURE INHALER SAFETY & PERFORMANCE: POLYMERS, COLOUR & ADDITIVES
Stephen J Duckworth describes some of the application of polymer colourants and additives in respiratory drug delivery devices, highlighting the strict regulatory environment.
PRODUCT SHOWCASE: BIOCORP’S INSPAIR<sup>™</sup>
PULMONARY
Jean Vuillecard
Biocorp
PRODUCT SHOWCASE: BIOCORP’S INSPAIR™
Inspair™ is a sensing technology able to measure inhalation metrics and therefore provide an accurate insight into actual doses consumed.
A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS
PREFILLED SYRINGES
Pascal Dugand
Nemera
A COLLABORATION THAT SAYS YOU’RE IN SAFE HANDS
William Dierick, Pascal Dugand and Adrien Tisserand describe a collaboration to create a compatibility between Terumo’s PLAJEX™; prefillable syringes with Nemera’s Safe‘n’Sound® platform of add-on passive sharps injury protection devices for PFS.
COMPANY SHOWCASE: AVERY DENNISON
INJECTION
COMPANY SHOWCASE: AVERY DENNISON
As labelling technology continues to develop, pharmaceutical labels are making an increasingly significant contribution to operational efficiencies, and to security and compliance. Smarter and more dependable labelling solutions are important in often safety-critical clinical environments.
SAFER PREFILLED SYRINGES & FEWER PROCESS CHANGES
PREFILLED SYRINGES
Jean Vuillecard
Biocorp
SAFER PREFILLED SYRINGES & FEWER PROCESS CHANGES
Jean Vuillecard, Philippe Lesaulnier and Eric Dessertenne explain how, despite great innovations, adopting new syringe safety systems has always been a trade-off between safety and the cost of implementing new processes and introduce Biocorp's Newguard™, a new passive safety system integrated on prefilled syringes without such compromises being required.
PRODUCT SHOWCASE: PREMIUMCOAT™
INJECTION
Anne Bailly
Aptar Pharma
PRODUCT SHOWCASE: PREMIUMCOAT™
PremiumCoat™ is a novel range of elastomeric stoppers developed by Aptar Pharma and based on an approved, pure, state-of-the-art formulation. The surface of the elastomer is coated during manufacturing with a thin fluoropolymer film.
THE ADD-ON APPROACH TO CONNECTIVITY
CONNECTIVITY
Christian Keller
SHL Medical
THE ADD-ON APPROACH TO CONNECTIVITY
William Cirillo and Christian Keller describe a simple add-on connected digital platform that can work with an existing delivery device. Digital health is an umbrella term that covers a lot of different applications of technology in the health industry. From wearable sensors and electronic health records to health apps, connected and digital solutions are becoming more accepted.
DRUGDELIVERYSYSTEM FOR 1 ML LONG PREFILLED SYRINGES
PREFILLED SYRINGES
Hans Peter Manser
DRUGDELIVERYSYSTEM FOR 1 ML LONG PREFILLED SYRINGES
Ludwig Weibel and Hans Peter Manser ask, how can drug delivery systems help in patient compliance? And what are the challenges to be encountered with novel drugs filled in 1 mL long prefilled syringes? A novel and innovative approach is presented meeting the requirements of today’s and future drug applications.
PACKAGING & MACHINERY ENGINEERED TO GO HAND-IN-HAND
INJECTION
Christoph Hammer
PACKAGING & MACHINERY ENGINEERED TO GO HAND-IN-HAND
Christoph Hammer explains how Dividella exclusively manufactures machines for packaging pharmaceutical products at its facility in Grabs, Switzerland. The focus is totally on the packaging of parenteral pharmaceuticals in Top-Load boxes. These sensitive products demand well thought-out packaging solutions.
ADAPTIQ<sup>®</sup> & VIALS DC
INJECTION
SCHOTT Pharma
ADAPTIQ® & VIALS DC
SCHOTT has expanded its adaptiQ® portfolio of ready-to-use pharma containers to meet growing market demand from drug manufacturers and, separately, a new series of studies has once again demonstrated the effectiveness of SCHOTT Vials Delamination Controlled (Vials DC).
MORE PRODUCT EFFICIENCY BY FULLY AUTOMATED PRODUCTION PROCESSES
INJECTION
Berthold Schopferer
MORE PRODUCT EFFICIENCY BY FULLY AUTOMATED PRODUCTION PROCESSES
Harry Pruner, Freelance Journalist, Pruner Marketing Services, gives a run-down of the machines and production lines manufactured by ZAHORANSKY for the production of ready-to-fill, prefillable syringes.
PATIENT-CENTRICITY & CONFIDENCE IN DEVICE DESIGN
PREFILLED SYRINGES
Alex Fong
Owen Mumford
PATIENT-CENTRICITY & CONFIDENCE IN DEVICE DESIGN
Alex Fong provides an overview and update on needlestick injury, its prevention and the market for needle safety devices, and introduces Unisafe™, Owen Mumford's springless, passive safety device designed to work with existing prefillable syringes.
SPRING DEVELOPMENT FOR MEDICAL DEVICES
EXPERT VIEW
Neil Fletcher
SPRING DEVELOPMENT FOR MEDICAL DEVICES
Neil Fletcher provides a spring manufacturer’s perspective of how springs can be used in medical devices, and how a lengthy and extensive device development process affects normal custom and practice in our industry. The report focuses on spring technology and highlights some of the challenges that spring manufacturers face daily.
SELECTION OF EXCIPIENTS FOR DRY POWDER INHALERS
EXPERT VIEW
Harry Peters
SELECTION OF EXCIPIENTS FOR DRY POWDER INHALERS
Harry Peters and Gerald Hebbink explain how, because dry powder inhalers need a carrier to help with ensuring the drug is effectively delivered, interest has been focused on developing inhalation-grade lactose for this purpose.
LEVERAGE TECH TO OVERCOME PULMONARY DELIVERY BARRIERS
PULMONARY
Jean Vuillecard
Biocorp
LEVERAGE TECH TO OVERCOME PULMONARY DELIVERY BARRIERS
Jean Vuillecard and Eric Dessertenne define the limitations of traditional strategies to train, educate and track adherence with inhaled therapeutics and show how connectivity and other add-on digital tech can support these strategies healthcare providers require.
PATIENT PREFERENCE: DEVICE TRAINING & EDUCATION TOOLS
PULMONARY
Paul Sullivan
Noble
PATIENT PREFERENCE: DEVICE TRAINING & EDUCATION TOOLS
Paul Sullivan and Craig Baker point out that most patients with asthma do not use their inhaler properly, and review evidence from a trial of five different methods designed to improve inhaler use. They conclude that training devices could be effective tools to increase patient confidence and reduce anxiety.
AN ENVIRONMENTALLY FRIENDLY & EFFICIENT DOSAGE FORM
PULMONARY
Susana Ecenarro Probst
Qualicaps
AN ENVIRONMENTALLY FRIENDLY & EFFICIENT DOSAGE FORM
Susana Ecenarro Probst presents evidence, set against the backdrop of environmental concerns over HFC propellants in MDIs, supporting the adoption of dry-powder inhalers as an attractive alternative.
LEARNING TO WALK BEFORE WE RUN
EXPERT VIEW
David Harris
LEARNING TO WALK BEFORE WE RUN
David Harris highlights basic problems with inhalers that persist today, and describes why - as the industry looks increasingly towards developing "smart" and connected inhalers - it is important to remember to solve these basic problems.
SCALING-UP FOR HIGH DOSE DELIVERY TO THE LUNGS
PULMONARY
Dr João Ventura Fernandes
SCALING-UP FOR HIGH DOSE DELIVERY TO THE LUNGS
João Ventura Fernandes, Gonçalo Rebelo de Andrade and Peter Villax describe the scaling up of the currently marketed TwinCaps® inhaler into the new TwinMax™ design for high-dose delivery of challenging drug-alone formulations in single to short-term treatments and emergency situations.
GENERIC NEBULISER BIOEQUIVALENCE: OPTIMISING ANALYTICAL STRATEGIES
PULMONARY
Déborah Le Pennec
Malvern Panalytical
GENERIC NEBULISER BIOEQUIVALENCE: OPTIMISING ANALYTICAL STRATEGIES
Déborah Le Pennec, Laurent Vecellio, Paul Kippax and Stephane Rouquette look at the optimal application of laser diffraction and automated imaging within the context of the US FDA guidance for the in vitro demonstration of bioequivalence in a generic nebuliser.
A TRUE PLATFORM OFFERING EFFICIENT NASAL DOSE DELIVERY
NASAL
Pascale Farjas
Nemera
A TRUE PLATFORM OFFERING EFFICIENT NASAL DOSE DELIVERY
Millions of people suffering from allergic rhinitis use nasal sprays manufactured by Nemera every day. Pascale Farjas, provides an overview of an innovative nasal delivery system, Advancia®, a true platform.
TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
PREFILLED SYRINGES
Orfeo Niedermann
Ypsomed
TRANSFORMING A PROVEN AUTOINJECTOR INTO A FULLY CONNECTED DEVICE
Orfeo Niedermann provides insights into how connectivity enhances existing autoinjectors and adds value for users, physicians, pharma companies and insurers.
THE DEVELOPMENT OF THE MOLLY<sup>®</sup> PLATFORM
PREFILLED SYRINGES
SHL Medical
THE DEVELOPMENT OF THE MOLLY® PLATFORM
SHL Group explores the growth of the Molly® family of drug delivery devices as an example of how the auto injector market has changed over the last five years, and looks to the future.
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
PREFILLED SYRINGES
Joe Reynolds
Noble
NOVEL APPROACHES INCREASE PATIENT CONFIDENCE & DECREASE ANXIETY
Joe Reynolds introduces the latest approaches and technologies – such as needle simulators – to equip patients for confident, anxiety-free self administration of parenteral drugs.

See what ondrugdelivery's readers and contributors think


Matt Kempton user photo
Matt Kempton
Snr Project Engineer
Corning Incorporated

I am extremely impressed with the comprehensive presentation of information and problem/solution points detailed ... Kudos to you for an extremely well written article with succinct and robust scientific body of knowledge.


Li-Chun Tsou, PhD, MBA
Principal Engineer
Merck & Co

Your website and publication is a great asset for me. I’d recommend your publication to my colleagues. I am sure that we will gain knowledge and update information through your timely report. Thanks for making it available.


Abby Lockwood Opus Strategy photo
Abby Lockwood
Consultant
Plan Strategic

ONdrugDelivery Magazine is a great resource that brings a lot of value to the work my team and I are doing in the area of drug delivery. The device-specific content as well as the broader discussions surrounding industry trends and issues are extremely informative and very well written.


Dr Cristian Vilos

I‘m working on the development of microparticles for the release of veterinary antibiotics, and polymeric nanoparticles for siRNA and chemotherapeutic delivery. ONdrugDelivery has been a very usefull platform to connect the scientific research, and marketed drug development.


Top